Pathogenesis and Clinical manifestations of Rickettsia rickettsii

Pathogenesis of Rickettsia rickettsii

  • Human gets infected when infected adult tick inoculates Rickettsia rickettsii into the skin while taking a blood meal.
  • It usually takes 6 hours of attachment and feeding before rickettsiae are transmitted to the host. Infection can also be transmitted occasionally by scratching and rubbing infectious tick feces into the abraded skin.
  • After inoculation, rickettsiae spread throughout the body via the bloodstream.
  • The outer membrane protein A (OmpA) expressed on the surface of R. rickettsii is responsible for the ability of the bacteria to adhere to endothelial cells and induce phagocytosis.
  • After the bacteria penetrate into the cell, they are released from the phagosome by  degradation of  the phagosome membrane by production of a phospholipase C.
  • R. rickettsii multiply and are propelled through the cytoplasm by polymerization of the host cell actin at one pole.
  • The organisms then spread to other endothelial cells through long cellular projections of the cell membrane.
  • The primary clinical manifestation results due to multiplication of rickettsiae in endothelial cells of small blood vessels with subsequent damage to the cells and leakage of the blood vessels and produce vasculitis characterized by lymphocytes that surround the blood vessels.
  • The effects of damage to foci of contiguous endothelial cells are visible in the skin, where dilation of the blood vessels first produces a pink rash.
  • The cells become swollen and necrotic; there is thrombosis of the vessel, leading to rupture and necrosis.
  • Vascular lesions are prominent in the skin, but vasculitis occurs in many organs and appears to be the basis of hemostatic disturbances.
  • Hypovolemia and hypoproteinemia caused by the loss of plasma into tissues can lead to reduced perfusion of various organs and organ failure.
  • Later, leakage of red blood cells results in hemorrhagic spots (or petechiae), from which the name of the disease is derived.
  • Within the blood vessels of the brain, lung, heart, liver, and other visceral organs, these pinpoint hemorrhages lead to encephalitis, pneumonitis, cardiac arrhythmia, nausea, vomiting, and abdominal pain.
  • The host immune response to infection is based on cytokine-mediated intracellular killing and clearance of intracellular rickettsiae from the endothelium is achieved through the strong effects of the immune system with important contributions by cell mediated immunity, particularly CD8 lypmphocytes and their cytokines, such as interferon-γ and tumor necrosis factor.
  • Antibody response to rickettsial outer membrane proteins may also be important.

Pathogenesis and Clinical manifestations of Rickettsia rickettsii

Clinical manifestations of Rickettsia rickettsii

Rocky Mountain spotted fever

  • Rocky Mountain spotted fever is a potentially lethal, but usually curable tickborne disease, and is the most common rickettsial infection caused by Rickettsia rickettsii.
  • The disease usually occurs with highest frequency during the warmer months when tick activity is greatest.
  • The incubation period is 7 days.
  • The onset of disease is heralded by a high fever and headache that may be associated with malaise, myalgias, nausea, vomiting, abdominal pain, and diarrhea.
  • A macular rash may develop after three or more days and typically appears initially on wrist, ankles, and palms and soles and then spreads to the trunk.
  • The rash can evolve to the “spotted” or petechial form, which is a harbinger of more severe disease and hemorrhagic.
  • Complications of Rocky Mountain spotted fever include neurologic manifestations (encephalitis), pulmonary and renal failure, and cardiac abnormalities.
  • The patient may die within 5 days of onset of symptoms with the overall mortality rate being nearly 4% despite effective antibiotic therapy.
  • Risk factors for fatal infection include older age, glucose-6-phosphate dehydrogenase deficiency and delayed tetracycline treatment.

About Author

Photo of author

Sagar Aryal, PhD

Dr. Sagar Aryal is a microbiologist, researcher, and science communicator from Nepal. He is also co-founder and Research Head of the Department of Natural Products at the Kathmandu Research Institute for Biological Sciences (KRIBS), where he leads research on natural product discovery and microbial biodiversity. Dr. Aryal earned his Ph.D. in Microbiology from Tribhuvan University, Kathmandu, Nepal, in 2025, supported by a DAAD Research Grant and a University Grants Commission (UGC) Nepal Ph.D. Fellowship. His research interests include Actinomycetes, Myxobacteria, microbial taxonomy, and natural products, particularly the discovery of bioactive compounds with potential pharmaceutical applications. He isolated and identified Nocardia nepalensis, a novel bacterial species from Nepal, contributing to understanding microbial diversity in the region. Dr. Aryal has published more than 16 research articles in international journals and contributed three book chapters to established academic publications. He has presented scientific research findings and developed international research collaborations through visits to more than 18 countries across Asia, Europe, North America, and Oceania. From 2023 to 2025, he served as the American Society for Microbiology (ASM) Young Ambassador to Nepal. Since December 2025, he has served as an Editorial Board Member of Scientific Reports, a Nature Portfolio journal. In recognition of his scientific contributions, Dr. Aryal received the NAST Science and Technology Youth Award 2025 from the Nepal Academy of Science and Technology. He previously received the Frs. Locke and Stiller Research Award (LSRA) for the 2017-2018 cycle from St. Xavier's College, Kathmandu, and a Nepal Academy of Science and Technology (NAST) Research Grant for 2017-2018. Alongside his scientific career, Dr. Aryal has more than 15 years of experience in blogging, content writing, and search engine optimization (SEO).

Leave a Comment